Ueno, T., Masuda, N., Kamigaki, S., Morimoto, T., Akiyama, F., Kurosumi, M., . . . Toi, M. (2018). A multicenter phase II trial of neoadjuvant letrozole plus low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer (JBCRG‐07): Therapeutic efficacy and clinical implications of circulating endothelial cells. Cancer Med.
Citação norma ChicagoUeno, Takayuki, et al. "A Multicenter Phase II Trial of Neoadjuvant Letrozole Plus Low‐dose Cyclophosphamide in Postmenopausal Patients With Estrogen Receptor‐positive Breast Cancer (JBCRG‐07): Therapeutic Efficacy and Clinical Implications of Circulating Endothelial Cells." Cancer Med 2018.
Citação norma MLAUeno, Takayuki, et al. "A Multicenter Phase II Trial of Neoadjuvant Letrozole Plus Low‐dose Cyclophosphamide in Postmenopausal Patients With Estrogen Receptor‐positive Breast Cancer (JBCRG‐07): Therapeutic Efficacy and Clinical Implications of Circulating Endothelial Cells." Cancer Med 2018.